T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy-Reference-Cited by-同舟云学术

T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy

Published:2004-05 Issue:1 Volume:59 Page:138-145
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Garg Amit K,Strom Eric A,McNeese Marsha D,Buzdar Aman U,Hortobagyi Gabriel N,Kuerer Henry M,Perkins George H,Singletary S.Eva,Hunt Kelly K,Sahin Asyegul,Schechter Naomi,Valero Vicente,Tucker Susan L,Buchholz Thomas A

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference19 articles.

1. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer;Lancet,2000

2. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy;Overgaard;N Engl J Med,1997

3. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen;Overgaard;Lancet,1999

4. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer;Ragaz;N Engl J Med,1997

5. The link between local recurrence and distant metastases in human breast cancer;Koscielny;Int J Radiat Oncol Biol Phys,1999

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term outcomes and risk profile of cT3N0 breast cancer treated with neoadjuvant chemotherapy and curative surgery;Journal of Medical Imaging and Radiation Oncology;2024-09-09

2. Nomogram-Based Risk Stratification to Identify Patients with T3N0M0 Breast Cancer with Survival Benefit from Postmastectomy Radiotherapy;Annals of Surgical Oncology;2023-12-12

3. Regional radiotherapy after primary systemic treatment for cN+ breast cancer patients;The Breast;2023-04

4. Multidisciplinary considerations in the management of breast cancer patients receiving neoadjuvant chemotherapy;Current Problems in Surgery;2022-09

5. De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03): 5-year follow-up results of a Dutch, prospective, registry study;The Lancet Oncology;2022-09